Affluent Medical SAS
PAR:AFME

Watchlist Manager
Affluent Medical SAS Logo
Affluent Medical SAS
PAR:AFME
Watchlist
Price: 1.435 EUR -4.01% Market Closed
Market Cap: 56.5m EUR

Wall Street
Price Targets

AFME Price Targets Summary
Affluent Medical SAS

Wall Street analysts forecast AFME stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for AFME is 3.723 EUR with a low forecast of 2.525 EUR and a high forecast of 4.83 EUR.

Lowest
Price Target
2.525 EUR
76% Upside
Average
Price Target
3.723 EUR
159% Upside
Highest
Price Target
4.83 EUR
237% Upside
Affluent Medical SAS Competitors:
Price Targets
300622
Doctorglasses Chain Co Ltd
71% Upside
9997
Kangji Medical Holdings Ltd
5% Downside
688050
Eyebright Medical Technology Beijing Co Ltd
61% Upside
NSPR
InspireMD Inc
135% Upside
688253
Innovita Biological Technology Co Ltd
24% Upside
YPSN
Ypsomed Holding AG
29% Upside
ALGN
Align Technology Inc
11% Upside
7979
Shofu Inc
45% Upside

Revenue
Forecast

Revenue Estimate
Affluent Medical SAS

For the last 7 years the compound annual growth rate for Affluent Medical SAS's revenue is 94%. The projected CAGR for the next 3 years is 54%.

94%
Past Growth
54%
Estimated Growth
N/A
Estimates Accuracy
N/A
Average

Operating Income
Forecast

Operating Income Estimate
Affluent Medical SAS

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-41%
Average Miss

Net Income
Forecast

Net Income Estimate
Affluent Medical SAS

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-35%
Average Miss
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is AFME's stock price target?
Price Target
3.723 EUR

According to Wall Street analysts, the average 1-year price target for AFME is 3.723 EUR with a low forecast of 2.525 EUR and a high forecast of 4.83 EUR.

What is Affluent Medical SAS's Revenue forecast?
Projected CAGR
54%

For the last 7 years the compound annual growth rate for Affluent Medical SAS's revenue is 94%. The projected CAGR for the next 3 years is 54%.

Back to Top